Delivery Order 75F40121D00018-75F40123F19003

Award Date 3/23/23
Potential Completion Date 9/30/23
Potential Value $240K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Takoma Park, MD 20901, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $145,636.17 firm fixed price delivery order to We Pharma, Inc. of Silver Spring, Maryland for pharmaceutical products to support domestic manufacturing. No set-aside provisions were applied to this contract. We Pharma will provide the FDA's Office of Pharmaceutical Quality with domestic pharmaceutical manufacturing supplies through September 30th, 2022 at their Silver Spring location. As the regulatory body...
<p>The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $409,719 firm fixed price delivery order contract to We Pharma, Inc., doing business as WEP Clinical, for Pharmaceutical Drug Product Orders. The contract has a period of performance starting on July 31, 2023 through August 6, 2024 and will be performed in Silver Spring, Maryland.</p>
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a firm fixed price delivery order contract to We Pharma, Inc. doing business as WEP Clinical, a self-certified small disadvantaged business, for the delivery of pharmaceutical drug products. The $182,616.74 award is in support of the FDA's research, regulatory compliance, and emergency response operations, and represents task orders under a larger 5-year, $6 million indefinite delivery contract awarded...
This delivery order against the Department of Health and Human Services Food and Drug Administration is for the purpose of obtaining currently marketed drug products for FDA research studies. Awarded on September 30, 2020 to We Pharma, Inc. located in Morrisville, North Carolina, this firm fixed price contract has a potential value of $246,754.22 and period of performance through September 29, 2021. No set-aside designation was applied. We Pharma Inc. will provide the requested drug products...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to We Pharma, Inc. doing business as WEP Clinical, a small disadvantaged business. The contract has a potential value of $365,000.00 and is for the delivery of physicochemical products in support of FDA research, regulatory compliance, and emergency response operations. The contract was awarded on June 29, 2018 with a completion date of July 15, 2023....
The Department of Health and Human Services Food and Drug Administration awarded a $2.4 million firm fixed price delivery order to Paragon Micro Inc. under the Solutions for Enterprise Wide Procurement V government-wide acquisition contract. The order is for Symantec maintenance and technical support services to be performed in Silver Spring, Maryland through March 2021. As the FDA regulates food, drugs, medical devices and cosmetics, this order will likely provide ongoing software licensing,...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $22,805.26 delivery order contract to Premier &amp; Companies, Inc. under the Multiple Award Schedule (MAS) vehicle. The contract is for CDER OBI DOCUMENT ROOM OFFICE SUPPLIES and will be performed in Silver Spring, Maryland through September 2024. The contract has a firm fixed price and is set aside for total small businesses. Premier &amp; Companies, Inc. will provide office supplies to support the HHS...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $66,145 firm fixed price delivery order to Data Federal Corporation under the agency's Multiple Award Schedule contract vehicle. The order is associated with the FDA's Shelf Life Extension Program and provides for electronic records storage and document management services to support the agency's efforts to extend expiration dates of stockpiled strategic national stockpile pharmaceuticals and medical...
The Department of Health and Human Services' Food and Drug Administration awarded a $663,035 delivery order to 4 Star Technologies Inc. under the Solutions for Enterprise Wide Procurement V government-wide acquisition contract vehicle. The order is for Centrify products to support the agency's IT security programs in Rockville, Maryland. As the FDA works to ensure the safety of medical products and protect public health, this contract will provide the identity and access management solutions...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $994,647.76 Purchase Order contract to Diant Pharma Inc. for a Pilot-Scale Nanoparticle Continuous Manufacturing System. Performance will take place in Storrs, Connecticut under firm fixed pricing terms. The contract begins on May 17, 2022 and concludes on November 29, 2023. Diant Pharma Inc. will provide pilot-scale continuous manufacturing equipment and services for developing nanoparticle drug...
  • 75F40121D00018
    Indefinite Delivery Contract
  • 75F40121D00018-75F40123F19003
    Delivery Order

This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is for $240,000 worth of pharmaceutical products to support domestic manufacturing and regulatory purposes. We Pharma, Inc. will provide the products in Takoma Park, Maryland by September 30, 2023 under a firm fixed price arrangement. As the FDA works to ensure the safety and effectiveness of drugs and medical devices, this contract will help the agency assess pharmaceutical manufacturing and meet its requirements without a set-aside designation. We Pharma does business as WEP Clinical and will deliver the requested products to aid the FDA in its important mission.

Generated 1/3/24, 11:40 AM